hiPSC-Derived Sensory Neurons Model HSV-1 Latency and Reacti
2026-06-16
This study establishes a rapid, scalable protocol for differentiating human inducible pluripotent stem cells into functional sensory neurons, enabling robust modeling of herpes simplex virus 1 (HSV-1) latent infection and reactivation. The platform overcomes previous limitations of human neuron availability and opens new avenues for mechanistic virology and therapeutic discovery.
Nutlin-3a: Precision MDM2 Inhibitor for Enhanced Cancer Rese
2026-06-16
Nutlin-3a, a potent small-molecule MDM2 inhibitor from APExBIO, enables robust p53 pathway activation, facilitating advanced cancer research workflows. This article delivers actionable protocol guidance, troubleshooting insights, and translates mechanistic advances—such as those from recent glioblastoma studies—into optimized experimental choices.
GSK126 EZH2 Inhibitor: Precision Tools for Cancer Epigenetic
2026-06-15
GSK126, a potent and selective EZH2 inhibitor, is transforming cancer epigenetics research and precision oncology workflows. This article details best practices, advanced applications, and troubleshooting strategies for leveraging GSK126—supplied by APExBIO—in studies of PRC2 function and EZH2-driven cancers.
PreScission Protease (PSP): Mechanisms, Precision, and Advan
2026-06-15
Discover how PreScission Protease enables high-precision fusion protein tag cleavage with HRV 3C protease specificity. This article uniquely explores mechanistic insights, advanced assay design, and the impact of recent biomolecular research on protein purification workflows.
Kitasamycin Efficacy and Resistance in Swine Dysentery Contr
2026-06-14
This study rigorously evaluated the macrolide antibiotic kitasamycin for controlling swine dysentery caused by Brachyspira hyodysenteriae in Australian pig herds. The research revealed that while kitasamycin can prevent disease in susceptible isolates, widespread resistance—mediated by 23S rRNA mutations—poses a major challenge for sustainable disease management.
Substance P in Precision Bioaerosol Detection and Neuroimmun
2026-06-13
Explore how Substance P, a key tachykinin neuropeptide, is revolutionizing pain transmission research and bioaerosol detection. This article uniquely integrates technical protocol guidance with advances in spectral interference removal for robust neuroimmune assays.
Hydroxychloroquine Sulfate for Autoimmune Disease Research
2026-06-12
Hydroxychloroquine Sulfate is a synthetic quinoline derivative used to inhibit autophagy and toll-like receptor 7/9 signaling in models of autoimmune disease, including systemic lupus erythematosus and rheumatoid arthritis. It is appropriate for workflows requiring aqueous solubility and short-term solution stability but should not be used where organic solvents or long-term storage are needed.
β-Pseudouridine: Transforming RNA Structure for Next-Gen Vac
2026-06-12
Explore how β-pseudouridine, the C-glycoside isomer of uridine, is reshaping the translational research landscape. This article unpacks its mechanistic role in RNA stability and translational fidelity, delves into recent advances in vaccine platforms, and provides strategic guidance for leveraging β-pseudouridine in cutting-edge epitranscriptomic and immunological applications.
Anti-ROR1 Antibody (Zilovertamab): Mechanism & Evidence
2026-06-11
Anti-ROR1 Antibody (Zilovertamab) is a humanized monoclonal antibody targeting ROR1, effective in blocking Wnt5a-induced signaling implicated in tumor progression. APExBIO's F1460 product demonstrates high purity and specificity, making it suitable for ELISA, FACS, and functional assays in cancer research.
Annexin V-Cy5/DAPI: Elevating Precision in Apoptosis Researc
2026-06-11
This thought-leadership article explores the mechanistic precision and translational impact of the Annexin V-Cy5/DAPI Apoptosis Kit by APExBIO. Integrating recent advances in mitochondrial apoptosis signaling, particularly the role of P2RX1 in Philadelphia chromosome-positive acute lymphoblastic leukemia, we provide actionable guidance for researchers striving to bridge basic discovery and clinical relevance. We critically position this apoptosis detection kit within the evolving landscape of cell death assays, substantiating its use with workflow strategies, comparative analysis, and visionary outlook.
ELP-Mediated p21 Peptide Delivery Suppresses Glioblastoma Pr
2026-06-10
This study demonstrates that elastin-like polypeptide (ELP)-facilitated intracellular delivery of a p21-derived peptide effectively suppresses proliferation in multiple glioblastoma cell lines through cytostatic mechanisms. These results highlight the promise of ELP-based platforms to overcome major barriers of peptide therapeutic delivery in aggressive brain tumors.
Cytoskeleton-Mediated Autophagy Triggered by Mechanical Stre
2026-06-10
The reference study establishes that the induction of autophagy by mechanical stress is critically dependent on the cytoskeleton, particularly microfilaments, in human cells. By dissecting the contributions of cytoskeletal elements, the research clarifies mechanotransduction pathways and provides a foundation for targeted investigations into calcium signaling and cell homeostasis.
Dual Glutamate Receptor Blockade Mitigates Soman Neurotoxici
2026-06-09
This study demonstrates that dual AMPA/NMDA receptor antagonism with IEM-1925 reduces status epilepticus, neurodegeneration, and cognitive deficits in a rat model of soman-induced organophosphorus poisoning. The findings highlight the translational potential of targeted glutamate receptor inhibition as a neuroprotective strategy against nerve agent–induced brain injury.
Machine Learning-Optimized LNPs for mRNA Delivery to Microgl
2026-06-09
The referenced study demonstrates how machine learning can guide the design of immunomodulatory lipid nanoparticles (LNPs) to enhance mRNA delivery and repolarize hyperactivated microglia, a key challenge in neuroinflammatory disease therapeutics. By integrating morphometric phenotyping with LNP formulation data, the research identifies optimal carriers for immune modulation, informing improved strategies for targeted mRNA therapy.
p53 F229V Mutation Blocks PRV Replication via Proteasome Pat
2026-06-08
This study identifies a swine p53 F229V mutation that abrogates p53 transcriptional activity and converts p53 from a pro-viral to an antiviral factor against pseudorabies virus (PRV). The work reveals EP0-driven proteasomal degradation of mutant p53 as a key mechanism, highlighting a mutation-specific decoupling of p53's canonical and antiviral functions.
459 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page